How can #data and #machinelearning influence commercialization strategies in the #pharma industry? Drew McCormick, head of data & analytics, shares his insights with INFORMS and Healthcare Analytics Magazine on how they can help predict telehealth usage. Read more: https://ow.ly/KcyG50TWLHi
About us
EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com.
- Website
-
http://eversana.com
External link for EVERSANA
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Chicago, IL
- Type
- Privately Held
- Specialties
- Regulatory, Management & Specialty Consulting, Research & Insights, Global Pricing Strategies, Patient, Payer & Provider Marketing Services, Field Medical, Market Access & Sales , Global Channel Management & 3PL, Specialty Pharmacy & In-Home Nursing, HUB & Adherence Solutions, Affordability Programs, Medical Communications & Pharmacovigilance, Revenue Management, Digital Strategies & Therapy Transformation, Patient Analytics Services, Integrated Patient-Level Data, Commercial Analytics Platform, RWE & HEOR Global Services, Global Launch Expertise, and Payer Reimbursement Strategies
Locations
Employees at EVERSANA
Updates
-
EVERSANA addresses both obvious and hidden barriers to patient adherence with innovative strategies and technologies. From pre-diagnosis to post-prescription, our comprehensive approach ensures better health outcomes and builds trust. Discover how we’re transforming patient journeys and making a real impact in this article by industry experts Maria Kirsch, Krista Pinto and Mike Scott. Download the full article: https://ow.ly/eyvM50TQX3Z
-
Global Insights from EVERSANA! Learn about the integration of AI in pharmacovigilance, the role of global hubs, and strategies for navigating regulatory bodies from Vikram Anand, MBA, PMP, ITIL. Read more in Pharmaceutical Executive: https://lnkd.in/gDndx4Aj #AI #Pharma #GlobalMarkets
-
Watch Chris Cameron, PhD, chief scientific officer, value and evidence, live at #ISPOREurope as he moderates two panels: 1. Role of Global Indirect Treatment Comparison (ITC) Programs in Supporting Europe’s Joint Clinical Assessments (JCAs): Insights From Global and EU Experts Tuesday, 19 November at 13:45 https://ow.ly/Cvq750TRNuM 2. Bridging Nations, Diverging Views: Exploring the Global Landscape of Indirect Treatment Comparisons Acceptance by Health Technology Assessment Bodies Wednesday, 20 November at 10:00 https://ow.ly/t0B550TRNuN Learn more and schedule a meeting: https://ow.ly/IPRv50TRNuL
-
EVERSANA proudly observed #NationalDisabilityEmploymentAwarenessMonth! We honor the invaluable contributions of workers with disabilities and reaffirm our commitment to fostering an inclusive workplace. Together, we celebrate the unique talents and perspectives that drive our collective success. 🔗 Learn more about how we recognized the month and learned about incorporating #inclusivity into the workplace: https://ow.ly/TXrS50TWhHi #NDEAM #EmbraceDiversity #Accessibility
-
Read the full article: https://ow.ly/KrQN50TBbR2 Achieving innovation in #RareDisease treatments is a complex endeavor, and the burden on patients, families and providers is immense. But with #ArtificialIntelligence and #MachineLearning, the potential to revolutionize diagnoses and care for those suffering from rare diseases is growing. Learn more in this article from Maria Bucceri Kirsch, Scott Snyder, Faruk Abdullah and Pierantonio Russo MD, FCPP, FAAP, STS about how AI and ML can analyze extensive amounts of data to inform groundbreaking research and progress in the rare disease space.
-
This #Diwali, our Mumbai and Pune offices came alive with the spirit of the Festival of Lights. From vibrant ethnic wear and creative activities in Mumbai to a delightful Diwali Mela in Pune, our celebrations were filled with joy, unity and cultural pride. Swipe through to see the highlights and hear from Amlan Basu, Senior Director, India HR on the importance of this beautiful festival: “Diwali, also called Deepavali, symbolizes the spiritual victory of light over darkness, good over evil, and knowledge over ignorance. It’s a time for us to come together, celebrate our shared values, and foster a sense of unity and belonging within EVERSANA. By celebrating Diwali, we honor our cultural heritage and create a vibrant, inclusive workplace where everyone feels valued and appreciated.” 🔗 See where EVERSANA calls ‘home’ around the world: https://lnkd.in/gu_JvdPZ 🔗 Join our growing global team: https://lnkd.in/g_AV3A4u 🔗 Meet our global experts: https://lnkd.in/ggRMCG3V #India #FestivalOfLights #Culture #WeAreEVERSANA
-
#Hiring: People Director (#HR) on-site in #Memphis! EVERSANA is seeking a seasoned HR leader with extensive experience in manufacturing and warehouse operations to spearhead our HR strategy for the Channel, #Warehouse Operations and #3PL group in Memphis. Proficiency in #Spanish is a valuable asset. This pivotal role offers the opportunity to make a significant impact from day 1. 🔗 Apply today: https://smrtr.io/nKwP6 #career #NowHiring #OpenRole
-
Learn more: https://ow.ly/hkPV50TEifY Launching in the EU/U.K. requires meticulous planning and execution. EVERSANA’s latest insights reveal a 7-step strategy to navigate this challenging landscape successfully. From timing your launch to establishing a robust pricing strategy, every step is crucial. Don’t leave your launch to chance. Partner with EVERSANA for expert guidance. #MarketAccess #ProductLaunch #EUUKMarket
-
Join EVERSANA at BIO-EUROPE SPRING, 4-6 November 2024 in Stockholm, Sweden. With over 40 clients and a growing number of engagements in Europe, EVERSANA is leading the way as the only end-to-end provider of #commercialisation services that span all stages of the product life cycle to deliver long-term value for patients, physicians and payers. Schedule a meeting today to meet with our team in Barcelona: https://ow.ly/wlYy50TEx6w. #BIOEurope